Integrated Filing — IndAS



General information about company

Scrip Code 513121
NSE Symbol ORICONENT
MSEI Symbol NOTLISTED
ISIN INE730A01022
Name of company Oricon Enterprises Limited
Type of company Main Board
Class of security Equity
Date of start of financial year 01-04-2025
Date of end of financial year 31-03-2026
Date of board meeting when results were approved 14-11-2025
Date on which prior intimation of the meeting for considering financial results was informed to the exchange 07-11-2025
Description of presentation currency INR
Level of rounding used in financial results Lakhs
Reporting Type Quarterly
Reporting Quarter Second quarter
Nature of report standalone or consolidated Consolidated
Whether results are audited or unaudited for the quarter ended Unaudited
Whether results are audited or unaudited for the Year to date for current period ended/year ended Unaudited
Segment Reporting Multi segment
Description of single segment
Start date and time of board meeting 14-11-2025   15:30:00
End date and time of board meeting 14-11-2025   20:15:00
Whether cash flow statement is applicable on company Yes
Type of cash flow statement Cash Flow Indirect
Declaration of unmodified opinion or statement on impact of audit qualification Not applicable



Financial Results Ind-AS

Amount in (Lakhs)

Particulars 3 months/ 6 months ended (dd-mm-yyyy) Year to date figures for current period ended (dd-mm-yyyy)
A Date of start of reporting period 01-07-2025 01-04-2025
B Date of end of reporting period 30-09-2025 30-09-2025
C Whether results are audited or unaudited Unaudited Unaudited
D Nature of report standalone or consolidated Consolidated Consolidated
1 Income
Revenue from operations 944.50 1,723.03
Other income 2,030.14 4,788.79
Total income 2,974.64 6,511.82
2 Expenses
(a) Cost of materials consumed 177.18 348.82
(b) Purchases of stock-in-trade 738.82 1,434.11
(c) Changes in inventories of finished goods, work-in-progress and stock-in-trade 7.62 (17.93)
(d) Employee benefit expense 341.74 710.03
(e) Finance costs 28.28 58.05
(f) Depreciation, depletion and amortisation expense 104.71 196.73
(f) Other Expenses
1 Store & Spares consumed 62.84 113.23
2 Other Expenses 531.31 1,053.20
Total other expenses 594.15 1,166.43
Total expenses 1,992.50 3,896.24
3 Total profit before exceptional items and tax 982.14 2,615.58
4 Exceptional items 0.00 0.00
5 Total profit before tax 982.14 2,615.58
6 Tax expense
7 Current tax 206.63 259.33
8 Deferred tax 57.11 436.94
9 Total tax expenses 263.74 696.27
10 Net movement in regulatory deferral account balances related to profit or loss and the related deferred tax movement 113.20 0.00
11 Net Profit Loss for the period from continuing operations 831.60 1,919.31
12 Profit (loss) from discontinued operations before tax 733.64 862.78
13 Tax expense of discontinued operations 477.64 510.10
14 Net profit (loss) from discontinued operation after tax 256.00 352.68
15 Share of profit (loss) of associates and joint ventures accounted for using equity method (208.78) (161.87)
16 Total profit (loss) for period 878.82 2,110.12
17 Other comprehensive income net of taxes (724.01) 369.84
18 Total Comprehensive Income for the period 154.81 2,479.96
19 Total profit or loss, attributable to
Profit or loss, attributable to owners of parent 878.82 2,110.12
Total profit or loss, attributable to non-controlling interests 0.00 0.00
20 Total Comprehensive income for the period attributable to
Comprehensive income for the period attributable to owners of parent 154.82 2,479.97
Total comprehensive income for the period attributable to owners of parent non-controlling interests 0.00 0.00
21 Details of equity share capital
Paid-up equity share capital 3,140.95 3,140.95
Face value of equity share capital 2 2
27 Details of debt securities
22 Reserves excluding revaluation reserve
23 Earnings per share
i Earnings per equity share for continuing operations
Basic earnings (loss) per share from continuing operations 0.4 1.12
Diluted earnings (loss) per share from continuing operations 0.4 1.12
ii Earnings per equity share for discontinued operations
Basic earnings (loss) per share from discontinued operations 0.16 0.22
Diluted earnings (loss) per share from discontinued operations 0.16 0.22
ii Earnings per equity share
Basic earnings (loss) per share from continuing and discontinued operations 0.56 1.34
Diluted earnings (loss) per share from continuing and discontinued operations 0.56 1.34
24 Debt equity ratio
25 Debt service coverage ratio
26 Interest service coverage ratio
27 Disclosure of notes on financial results



Remarks

Debt equity ratio
Debt service coverage ratio
Interest service coverage ratio


Statement of Asset and Liabilities

Amount in (Lakhs)

Particulars Year ended (dd-mm-yyyy)
Date of start of reporting period 01-04-2025
Date of end of reporting period 30-09-2025
Whether results are audited or unaudited Unaudited
Nature of report standalone or consolidated Consolidated
Assets
1 Non-current assets
Property, plant and equipment 23,366.18
Capital work-in-progress 1,642.63
Investment property 2,555.61
Goodwill 8,595.11
Other intangible assets 0.00
Intangible assets under development
Biological assets other than bearer plants
Investments accounted for using equity method 174.80
Non-current financial assets
Non-current investments 56,146.33
Trade receivables, non-current 0.00
Loans, non-current 1,600.74
Other non-current financial assets 1,593.19
Total non-current financial assets 59,340.26
Deferred tax assets (net) 143.86
Other non-current assets 867.13
Total non-current assets 96,685.58
2 Current assets
Inventories 1,033.74
Current financial asset
Current investments 9,460.79
Trade receivables, current 1,182.33
Cash and cash equivalents 820.74
Bank balance other than cash and cash equivalents 2,168.40
Loans, current 13,283.84
Other current financial assets 2,048.28
Total current financial assets 28,964.38
Current tax assets (net) 0.00
Other current assets 406.68
Total current assets 30,404.80
3 Non-current assets classified as held for sale 10,351.48
4 Regulatory deferral account debit balances and related deferred tax Assets 0.00
Total assets 1,37,441.86
Equity and liabilities
1 Equity
Equity attributable to owners of parent
Equity share capital 3,141.49
Other equity 1,23,774.02
Total equity attributable to owners of parent 1,26,915.51
Non controlling interest 0.70
Total equity 1,26,916.21
2 Liabilities
Non-current liabilities
Non-current financial liabilities
Borrowings, non-current 269.72
Trade payables, non-current
(A) Total outstanding dues of micro enterprises and small enterprises 0.00
(B) Total outstanding dues of creditors other than micro enterprises and small enterprises 0.00
Total Trade payable 0.00
Other non-current financial liabilities 1,015.67
Total non-current financial liabilities 1,285.39
Provisions, non-current 503.78
Deferred tax liabilities (net) 1,412.28
Deferred government grants, Non-current 0.00
Other non-current liabilities 83.53
Total non-current liabilities 3,284.98
Current liabilities
Current financial liabilities
Borrowings, current 701.42
Trade payables, current
(A) Total outstanding dues of micro enterprises and small enterprises 0.00
(B) Total outstanding dues of creditors other than micro enterprises and small enterprises 780.23
Total Trade payable 780.23
Other current financial liabilities 48.23
Total current financial liabilities 1,529.88
Other current liabilities 2,445.33
Provisions, current 99.86
Current tax liabilities (Net) 556.78
Deferred government grants, Current 0.00
Total current liabilities 4,631.85
3 Liabilities directly associated with assets in disposal group classified as held for sale 2,608.82
4 Regulatory deferral account credit balances and related deferred tax liability 0.00
Total liabilities 10,525.65
Total equity and liabilites 1,37,441.86
Disclosure of notes on assets and liabilities



Format for Reporting Segment wise Revenue, Results and Capital Employed along with the company results

Amount in (Lakhs)

Particulars 3 months/ 6 month ended (dd-mm-yyyy) Year to date figures for current period ended (dd-mm-yyyy)
Date of start of reporting period 01-07-2025 01-04-2025
Date of end of reporting period 30-09-2025 30-09-2025
Whether results are audited or unaudited Unaudited Unaudited
Nature of report standalone or consolidated Consolidated Consolidated
1 Segment Revenue (Income)
(net sale/income from each segment should be disclosed)
1 Packaging 0.0041866 0.0079622
2 Others 0.0075953 1,461.45
3 Discontinued Operations 3,753.71 8,084.93
Total Segment Revenue 4,931.90 10,342.60
Less: Inter segment revenue 233.69 534.65
Revenue from operations 4,698.21 9,807.95
2 Segment Result
Profit (+) / Loss (-) before tax and interest from each segment
1 Packaging 140.87 (124.08)
2 Others 20.70 27.34
3 Discontinued Operations 354.52 483.46
Total Profit before tax 516.09 386.72
i. Finance cost 28.28 58.05
ii. Other Unallocable Expenditure net off Unallocable income (753.08) (2,608.51)
Profit before tax 1,240.89 2,937.18
3 (Segment Asset - Segment Liabilities)
Segment Asset
1 Packaging 3,064.85 3,064.85
2 Others 2,442.93 2,442.93
3 Discontinued Operations 8,292.29 8,292.29
Total Segment Asset 13,800.07 13,800.07
Un-allocable Assets 1,23,641.79 1,23,641.79
Net Segment Asset 1,37,441.86 1,37,441.86
4 Segment Liabilities
Segment Liabilities
1 Packaging 256.36 256.36
2 Others 960.51 960.51
3 Discontinued Operations 2,608.82 2,608.82
Total Segment Liabilities 3,825.69 3,825.69
Un-allocable Liabilities 4,826.40 4,826.40
Net Segment Liabilities 8,652.09 8,652.09
Disclosure of notes on segments



Other Comprehensive Income

Amount in (Lakhs)

Particulars 3 months/ 6 months ended (dd-mm-yyyy) Year to date figures for current period ended (dd-mm-yyyy)
A Date of start of reporting period 01-07-2025 01-04-2025
B Date of end of reporting period 30-09-2025 30-09-2025
C Whether results are audited or unaudited Unaudited Unaudited
D Nature of report standalone or consolidated Consolidated Consolidated
Other comprehensive income [Abstract]
1 Amount of items that will not be reclassified to profit and loss
1 Remeasurement of defined benefit plans -1120000 -2240000
2 Equity instruments through OCI -121107000 -4463000
3 Change in revaluation surplus - Freehold Land 0 0
4 Deferred Tax on above -1966000 -18364000
Total Amount of items that will not be reclassified to profit and loss (1,241.93) (250.67)
2 Income tax relating to items that will not be reclassified to profit or loss 0.00 0.00
3 Amount of items that will be reclassified to profit and loss
1 Exchange differences in translating to Financial statements of a foreign operation 49634000 49120000
2 Debt instruments through OCI 2158000 12931000
Total Amount of items that will be reclassified to profit and loss 517.92 620.51
4 Income tax relating to items that will be reclassified to profit or loss 0.00 0.00
5 Total Other comprehensive income (724.01) 369.84



Cash flow statement, indirect

Amount in (Lakhs)

Particulars Year ended (dd-mm-yyyy)
A Date of start of reporting period 01-04-2025
B Date of end of reporting period 30-09-2025
C Whether results are audited or unaudited Unaudited
D Nature of report standalone or consolidated Consolidated
Statement of cash flows
Cash flows from used in operating activities
Profit before tax 2,615.58
Adjustments for reconcile profit (loss)
Adjustments for finance costs 0.00
Adjustments for decrease (increase) in inventories 50.05
Adjustments for decrease (increase) in trade receivables, current 428.94
Adjustments for decrease (increase) in trade receivables, non-current 0.00
Adjustments for decrease (increase) in other current assets 0.00
Adjustments for decrease (increase) in other non-current assets 0.00
Adjustments for other financial assets, non-current 210.65
Adjustments for other financial assets, current 0.00
Adjustments for other bank balances 0.00
Adjustments for increase (decrease) in trade payables, current (1,493.86)
Adjustments for increase (decrease) in trade payables, non-current 0.00
Adjustments for increase (decrease) in other current liabilities 1,532.03
Adjustments for increase (decrease) in other non-current liabilities 0.00
Adjustments for depreciation and amortisation expense 348.26
Adjustments for impairment loss reversal of impairment loss recognised in profit or loss 0.00
Adjustments for provisions, current 55.66
Adjustments for provisions, non-current 0.00
Adjustments for other financial liabilities, current (1,033.51)
Adjustments for other financial liabilities, non-current 0.00
Adjustments for unrealised foreign exchange losses gains 0.00
Adjustments for dividend income 0.00
Adjustments for interest income 0.00
Adjustments for share-based payments 0.00
Adjustments for fair value losses (gains) 100.52
Adjustments for undistributed profits of associates 0.00
Other adjustments for which cash effects are investing or financing cash flow 0.00
Other adjustments to reconcile profit (loss) 0.00
Other adjustments for non-cash items 0.00
Share of profit and loss from partnership firm or association of persons or limited liability partnerships 0.00
Total adjustments for reconcile profit (loss) 198.74
Net cash flows from (used in) operations 2,814.32
Dividends received (287.49)
Interest paid 50.46
Interest received 0.00
Income taxes paid (refund) 0.00
Other inflows (outflows) of cash (936.98)
Net cash flows from (used in) operating activities 1,539.39
Cash flows from used in investing activities
Cash flows from losing control of subsidiaries or other businesses 0.00
Cash flows used in obtaining control of subsidiaries or other businesses 0.00
Other cash receipts from sales of equity or debt instruments of other entities 0.00
Other cash payments to acquire equity or debt instruments of other entities 0.00
Other cash receipts from sales of interests in joint ventures 0.00
Other cash payments to acquire interests in joint ventures 0.00
Cash receipts from share of profits of partnership firm or association of persons or limited liability partnerships 0.00
Cash payment for investment in partnership firm or association of persons or limited liability partnerships 0.00
Proceeds from sales of property, plant and equipment 2,960.29
Purchase of property, plant and equipment (534.20)
Proceeds from sales of investment property 534.42
Purchase of investment property 3,637.55
Proceeds from sales of intangible assets 0.00
Purchase of intangible assets 0.00
Proceeds from sales of intangible assets under development 0.00
Purchase of intangible assets under development 0.00
Proceeds from sales of goodwill 0.00
Purchase of goodwill 0.00
Proceeds from biological assets other than bearer plants 0.00
Purchase of biological assets other than bearer plants 0.00
Proceeds from government grants 0.00
Proceeds from sales of other long-term assets 0.00
Purchase of other long-term assets 0.00
Cash advances and loans made to other parties 4,284.47
Cash receipts from repayment of advances and loans made to other parties 0.00
Cash payments for future contracts, forward contracts, option contracts and swap contracts 0.00
Cash receipts from future contracts, forward contracts, option contracts and swap contracts 0.00
Dividends received 287.49
Interest received 1,840.18
Income taxes paid (refund) 0.00
Other inflows (outflows) of cash 936.98
Net cash flows from (used in) investing activities (828.46)
Cash flows from used in financing activities
Proceeds from changes in ownership interests in subsidiaries 0.00
Payments from changes in ownership interests in subsidiaries 0.00
Proceeds from issuing shares 0.00
Proceeds from issuing other equity instruments 0.00
Payments to acquire or redeem entity's shares 0.00
Payments of other equity instruments 0.00
Proceeds from exercise of stock options 0.00
Proceeds from issuing debentures notes bonds etc 0.00
Proceeds from borrowings 0.00
Repayments of borrowings (74.41)
Payments of lease liabilities 46.35
Dividends paid 785.65
Interest paid 50.47
Income taxes paid (refund) 0.00
Other inflows (outflows) of cash 0.00
Net cash flows from (used in) financing activities (808.06)
Net increase (decrease) in cash and cash equivalents before effect of exchange rate changes (97.13)
Effect of exchange rate changes on cash and cash equivalents
Effect of exchange rate changes on cash and cash equivalents 0.00
Net increase (decrease) in cash and cash equivalents (97.13)
Cash and cash equivalents cash flow statement at beginning of period 918.27
Cash and cash equivalents cash flow statement at end of period 821.14